Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kim

Showing results (251-260 of 259) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 259 results.
Cancer Cell|April 3, 2018
Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic CancerYing-Nai Wang, Heng-Huan Lee, Chao-Kai Chou, et al.
Nature Communications|October 22, 2020
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancersSherille D Bradley, Amjad H Talukder, Ivy Lai, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2022
Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase 1 Trial and Imaging-based Biomarker ValidationEugene J Koay, Mohamed Zaid, Maureen Aliru, et al.
Science Advances|March 13, 2024
Clonal dominance defines metastatic dissemination in pancreatic cancerI-Lin Ho, Chieh-Yuan Li, Fuchenchu Wang, et al.
Pancreas|March 30, 2026
Whole Metagenomic Profiling Identifies a Gut Microbial Signature for Chronic Pancreatitis via Machine LearningThais F Bartelli, Seyda Baydogan, Ismet Sahin, et al.
Nature Communications|July 31, 2021
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinomaVirginia Giuliani, Meredith A Miller, Chiu-Yi Liu, et al.
Science (New York, N.Y.)|September 16, 2017
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabineLeore T Geller, Michal Barzily-Rokni, Tal Danino, et al.
Nature Biotechnology|May 25, 2023
Sequencing by avidity enables high accuracy with low reagent consumptionSinan Arslan, Francisco J Garcia, Minghao Guo, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 28, 2024
2024 Canadian Surgery Forum: Sept. 25-28, 2024Christine Li, Michael Guo, Ahmer Karimuddin, et al.
Pageof 26

Showing results (251-260 of 259) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 259 results.
Cancer Cell|April 3, 2018
Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic CancerYing-Nai Wang, Heng-Huan Lee, Chao-Kai Chou, et al.
Nature Communications|October 22, 2020
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancersSherille D Bradley, Amjad H Talukder, Ivy Lai, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2022
Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase 1 Trial and Imaging-based Biomarker ValidationEugene J Koay, Mohamed Zaid, Maureen Aliru, et al.
Science Advances|March 13, 2024
Clonal dominance defines metastatic dissemination in pancreatic cancerI-Lin Ho, Chieh-Yuan Li, Fuchenchu Wang, et al.
Pancreas|March 30, 2026
Whole Metagenomic Profiling Identifies a Gut Microbial Signature for Chronic Pancreatitis via Machine LearningThais F Bartelli, Seyda Baydogan, Ismet Sahin, et al.
Nature Communications|July 31, 2021
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinomaVirginia Giuliani, Meredith A Miller, Chiu-Yi Liu, et al.
Science (New York, N.Y.)|September 16, 2017
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabineLeore T Geller, Michal Barzily-Rokni, Tal Danino, et al.
Nature Biotechnology|May 25, 2023
Sequencing by avidity enables high accuracy with low reagent consumptionSinan Arslan, Francisco J Garcia, Minghao Guo, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 28, 2024
2024 Canadian Surgery Forum: Sept. 25-28, 2024Christine Li, Michael Guo, Ahmer Karimuddin, et al.
Pageof 26